Alembic Pharma receives USFDA approval for schizophrenia drug Paliperidone Extended Release Ruchika Sharma27 Sept 2024 4:40 PM ISTMumbai: Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug Administration (USFDA)...
Rare case of Self-evisceration as initial presentation of schizoaffective disorder: A report Dr. Shivi Kataria3 Sept 2023 8:00 PM ISTschizoaffective disorder is typically diagnosed in adolescence and young adulthood characterized by major mood episodes and symptoms of schizophrenia...
Cardiovascular Risk significantly increases in patients With serious mental disorders Dr. Nandita Mohan17 March 2022 10:31 PM ISTA study in Journal of the American Heart Association compared estimated 10‐year and 30‐year cardiovascular risk in primary care patients with and...
Brain scans could help identify women with Postpartum psychosis risk Hina Zahid25 May 2021 9:00 PM ISTPostpartum psychosis is a devastating, but rare, mental health problem that affects women in the first few weeks after giving birth. Symptoms vary...
Study finds evidence of bartonella infection in schizophrenia patients Hina Zahid30 March 2021 9:38 AM ISTA pilot study from North Carolina State University and the University of North Carolina at Chapel Hill has found evidence of Bartonella infection in...
